S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Stock market today: Global markets are mixed as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
TKO Group Knocks Out WrestleMania Event Record
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Novo Nordisk Arms Wegovy to Be a Triple Threat
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Stock market today: Global markets are mixed as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
TKO Group Knocks Out WrestleMania Event Record
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Novo Nordisk Arms Wegovy to Be a Triple Threat
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Stock market today: Global markets are mixed as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
TKO Group Knocks Out WrestleMania Event Record
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Novo Nordisk Arms Wegovy to Be a Triple Threat
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Did You Miss the Gold Rush? Try These 2 Silver Stocks
Stock market today: Global markets are mixed as Middle East tensions escalate
Citi’s Results Say This About The Stock Market
TKO Group Knocks Out WrestleMania Event Record
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
Novo Nordisk Arms Wegovy to Be a Triple Threat

Daré Bioscience (DARE) Short Interest Ratio & Short Volume

$0.47
-0.01 (-2.61%)
(As of 04/12/2024 08:51 PM ET)

Daré Bioscience Short Interest Data

Current Short Volume
235,000 shares
Previous Short Volume
456,200 shares
Change Vs. Previous Month
-48.49%
Dollar Volume Sold Short
$115,197.00
Short Interest Ratio / Days to Cover
0.6
Last Record Date
March 31, 2024
Outstanding Shares
100,580,000 shares
Percentage of Shares Shorted
0.23%
Today's Trading Volume
94,200 shares
Average Trading Volume
385,277 shares
Today's Volume Vs. Average
24%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Daré Bioscience ?

Sign up to receive the latest short interest report for Daré Bioscience and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

DARE Short Interest Over Time

DARE Days to Cover Over Time

DARE Percentage of Float Shorted Over Time

Daré Bioscience Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/2024235,000 shares $115,197.00 -48.5%N/A0.6 $0.49
3/15/2024456,200 shares $213,684.08 -14.0%N/A1.1 $0.47
2/29/2024530,500 shares $304,507.00 +5.2%N/A0.8 $0.57
2/15/2024504,200 shares $184,385.94 -10.1%N/A0.8 $0.37
1/31/2024560,900 shares $182,292.50 -11.3%N/A1 $0.33
1/15/2024632,000 shares $229,795.20 -27.3%N/A1.1 $0.36
12/31/2023869,800 shares $268,768.20 -11.2%N/A1.6 $0.31
12/15/2023979,200 shares $344,580.48 +76.8%N/A2 $0.35
11/30/2023553,900 shares $193,865.00 +23.9%N/A1.3 $0.35
11/15/2023447,000 shares $152,963.40 -22.6%N/A1.8 $0.34
10/31/2023577,300 shares $247,084.40 +0.9%N/A2.5 $0.43
10/15/2023572,300 shares $263,258.00 -4.7%N/A2.4 $0.46
9/30/2023600,300 shares $277,218.54 +4.8%N/A2.2 $0.46
9/15/2023572,800 shares $292,128.00 -31.6%N/A1.9 $0.51
8/31/2023836,800 shares $572,622.24 +19.4%N/A2.7 $0.68
8/15/2023700,900 shares $515,091.41 +11.6%N/A2.4 $0.73
7/31/2023628,300 shares $469,151.61 -9.3%N/A2.2 $0.75
7/15/2023692,400 shares $602,388.00 +45.1%N/A2.6 $0.87
6/30/2023477,100 shares $434,208.71 +29.4%N/A2.2 $0.91
6/15/2023368,600 shares $353,856.00 +7.6%N/A1.9 $0.96
5/31/2023342,600 shares $346,026.00 -9.5%N/A1.8 $1.01
5/15/2023378,600 shares $382,386.00 -25.9%N/A2 $1.01
4/30/2023511,000 shares $511,000.00 -16.6%N/A2.5 $1.00
4/15/2023612,400 shares $618,524.00 +12.5%N/A2.2 $1.01
3/31/2023544,400 shares $566,176.00 +16.8%N/A1.8 $1.04
3/15/2023466,000 shares $466,000.00 -15.9%N/A1.5 $1.00
2/28/2023554,100 shares $576,264.00 -49.6%N/A1.8 $1.04
2/15/20231,100,000 shares $1.24 million -38.6%N/A3.5 $1.13
1/31/20231,790,000 shares $2.27 million +51.7%N/A5.7 $1.27
1/15/20231,180,000 shares $1.42 million -13.2%N/A5.1 $1.20
12/30/20221,360,000 shares $1.13 million +33.3%N/A5.7 $0.83
12/15/20221,020,000 shares $922,080.00 -12.8%N/A4.1 $0.90
11/30/20221,170,000 shares $1.04 million +4.5%N/A4.5 $0.89
11/15/20221,120,000 shares $1.06 million -0.9%N/A4.1 $0.95
10/31/20221,130,000 shares $1.10 million -8.1%N/A3.8 $0.97
10/15/20221,230,000 shares $1.10 million -12.1%N/A3.7 $0.89
9/30/20221,400,000 shares $1.40 million -0.7%N/A3.6 $1.00
9/15/20221,410,000 shares $1.55 million -3.4%N/A2.2 $1.10
8/31/20221,460,000 shares $1.58 million -2.7%N/A2 $1.08
8/15/20221,500,000 shares $1.89 million +2.7%N/A1.8 $1.26
Elon Musk Secret Crypto Plot Exposed (Ad)

Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.

Click here now to get your copy.

DARE Short Interest - Frequently Asked Questions

What is Daré Bioscience's current short interest?

Short interest is the volume of Daré Bioscience shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 235,000 shares of DARE short. Learn More on Daré Bioscience's current short interest.

What is a good short interest ratio for Daré Bioscience?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DARE shares currently have a short interest ratio of 1.0. Learn More on Daré Bioscience's short interest ratio.

Which institutional investors are shorting Daré Bioscience?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Daré Bioscience: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Daré Bioscience's short interest increasing or decreasing?

Daré Bioscience saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 235,000 shares, a decrease of 48.5% from the previous total of 456,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Daré Bioscience's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Daré Bioscience: Rockwell Medical, Inc. (2.54%), ProMIS Neurosciences, Inc. (0.17%), CalciMedica, Inc. (0.79%), Ocuphire Pharma, Inc. (6.33%), Unicycive Therapeutics, Inc. (1.03%), Bolt Biotherapeutics, Inc. (8.20%), BriaCell Therapeutics Corp. (4.83%), Cara Therapeutics, Inc. (5.56%), NRx Pharmaceuticals, Inc. (6.65%), Xilio Therapeutics, Inc. (0.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Daré Bioscience stock?

Short selling DARE is an investing strategy that aims to generate trading profit from Daré Bioscience as its price is falling. DARE shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Daré Bioscience?

A short squeeze for Daré Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DARE, which in turn drives the price of the stock up even further.

How often is Daré Bioscience's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DARE, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:DARE) was last updated on 4/15/2024 by MarketBeat.com Staff

From Our Partners